Compare LUNG & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | ATGL |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 154.9M |
| IPO Year | 2020 | 2023 |
| Metric | LUNG | ATGL |
|---|---|---|
| Price | $2.80 | $8.90 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.70 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 102.1K |
| Earning Date | 10-27-2026 | 01-27-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,497,000.00 | N/A |
| Revenue This Year | $0.33 | N/A |
| Revenue Next Year | $8.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $3.97 |
| 52 Week High | $3.25 | $50.00 |
| Indicator | LUNG | ATGL |
|---|---|---|
| Relative Strength Index (RSI) | 59.02 | 53.51 |
| Support Level | $1.26 | $7.24 |
| Resistance Level | $3.25 | $11.20 |
| Average True Range (ATR) | 0.37 | 0.83 |
| MACD | 0.01 | -0.21 |
| Stochastic Oscillator | 52.13 | 29.46 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Alpha Technology Group Ltd is a Hong Kong-based AI company. Its business focuses on two main directions: building Exclusive Large Language Model solutions and developing AI Agents. The group specializes in creating Exclusive Large Language Models (LLMs) and bespoke AI platforms. These solutions serve as custom AI brains, enabling enterprises to harness their data for strategic decision-making and operational performance. It guides companies of all sizes through digital transformation with scalable, AI-driven solutions that are ESG-sustainable and designed for long-term growth. The cutting-edge offerings, AlphaClaw AI Agents and the AlphaClaw AI Agent Marketplace to empower organizations across diverse industries to optimize operations, automate workflows, and unlock data-driven insights.